peripheral neuropathy

Peripheral neuropathy, affecting about 30 million Americans, damages nerves outside the brain and spinal cord, primarily in the feet and hands.

One of the most difficult conditions to treat, neuropathic pain is often sedated with opioids—now, on the horizon, may be a safer, non-addictive alternative.

As the rate of vaccination increases so has the incidence of GBS—particularly after viral vector-based vaccines such as AstraZeneca.

Peripheral neuropathy, affecting about 30 million Americans, damages nerves outside the brain and spinal cord, primarily in the feet and hands.

One of the most difficult conditions to treat, neuropathic pain is often sedated with opioids—now, on the horizon, may be a safer, non-addictive alternative.

As the rate of vaccination increases so has the incidence of GBS—particularly after viral vector-based vaccines such as AstraZeneca.